TORONTO--(BUSINESS WIRE)--Nov. 11, 2008--Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company will participate at the 2008 Annual Credit Suisse Health Care Conference at the Arizona Biltmore Resort in Phoenix, Arizona and at the Lazard Capital Markets 5th Annual Healthcare Conference at the St. Regis Hotel in New York City.
Biovail's Credit Suisse presentation is scheduled for Thursday, November 13, 2008 at 10a.m. MST (12p.m. EST). The Lazard Capital Markets presentation is scheduled for Tuesday, November 18, 2008 at 9:25a.m. EST. A live and archived Webcast, in addition to presentation slides, will be available on the Investor Relations page of Biovail's Web site at www.biovail.com.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company's Web site at www.biovail.com.
For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to [email protected].
CONTACT: Biovail Corporation Nelson F. Isabel,
(905) 286-3000 Vice President,
Investor Relations & Corporate
Communications SOURCE: Biovail Corporation
